Table of Contents

Methods
1: Wendy J. Ungar & Andreas Gerber: The uniqueness of child health and challenges to measuring costs and consequences
2: Katherine Bevans & Christopher B. Forrest: The reliability and validity of children's and adolescents' self-reported health
3: Werner B.F. Brouwer, N. Job A. van Exel & J. Mick Tilford: Incorporating caregiver and family effects in economic evaluations of child health
4: Lillian Sung, Stavros Petrou & Wendy J. Ungar: Measurement of health utilities in children
5: Andrew R Willan: The use of value of information methods in the design and evaluation of clinical trials
Applications
6: Scott D. Grosse: Economic evaluations of newborn screening
7: Kim Dalziel & Leonie Segal: Economic evaluation in child protection: what are the special challenges? Part 1. Economic evaluation in child protection
E. Michael Foster: Economic evaluation in child protection: what are the special challenges? Part 2. Economic evaluation in child welfare
Y. Ingrid Goh, Gideon Koren & Wendy J. Ungar: Economic evaluation in child protection: what are the special challenges? Part 3. Economic evaluation in Fetal Alcohol Spectrum Disorder
8: Sarah Byford: Obstacles to the economic evaluation of specialist child and adolescent mental health services
9: J. Mick Tilford & Ali I. Raja: Is more aggressive treatment of pediatric traumatic brain injury worth it?
10: Jonathan D. Campbell & Sean D. Sullivan: Economic evaluations in the management of paediatric asthma
11: Damian G Walker, Philippe Beutels & Raymond Hutubessy: Economic evaluation of childhood vaccines
12: Donald S. Shepard & Jose A. Suaya: Economic evaluation of dengue prevention
Using Evidence for Decision-Making
13: Tessa Tan-Torres Edejer, Moses Aikins, Robert Black, Lara Wolfson, Raymond Hutubessy & David B. Evans: Economic evaluations of interventions for children in the developing world: the WHO-CHOICE approach
14: Gillian Currie, Sarah Curtis & Terry Klassen: Evidence-based decision-making in child health: the role of clinical research and economic evaluation
15: Stavros Petrou: Should health gains by children be given the same value as health gains by adults in an economic evaluation framework?
16: Vania Costa & Wendy J. Ungar: Health-technology assessment in child health

About the Author

Wendy Ungar MSc, PhD is a Senior Scientist in Child Health Evaluative Sciences at the Hospital for Sick Children, Toronto, Canada, an Associate Professor in Health Policy, Management and Evaluation, University of Toronto, and an Adjunct Scientist at the Institute for Clinical Evaluative Sciences, Toronto, Canada. Dr. Ungar is the University of Toronto Program Director for the International Masters in Health Technology Assessment & Management (Ulysses
program) and has held a Canadian Institutes of Health Research New Investigator career award.
Dr. Ungar leads a program of research in the application of health economic methods to the paediatric population and also investigates the relationship between policies governing access to prescription medicines and health outcomes in children. Dr. Ungar and her research team created and maintain the PEDE database (http://pede.ccb.sickkids.ca/pede/), a popular on-line health technology assessment tool for examining health economic evidence in children.